Found 1462 matching trials
Radiation Therapy in Unresectable Gall Bladder Cancer PHASE2 The goal of this clinical trial is to compare two treatment regimes, namely...
Show More Location
Tata Memorial Centre
Learn More & Join Trial
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer PHASE3 This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma PHASE2 The investigators conducted a phase II, prospective, two-arm clinical study...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04) PHASE3 This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Show More Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Learn More & Join Trial
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial PHASE2 The investigators preliminary data suggests that FOLFOX-A may have equal or...
Show More Learn More & Join Trial
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC PHASE2 This is a prospective, multi-center, single arm study assessing the efficac...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer PHASE2 This is a prospective, single-arm trial. The main purpose of the study is t...
Show More Location
Zhejiang Provincial People's Hospital
Learn More & Join Trial
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma PHASE2 The aim of the study is to determine if intervening with combined local the...
Show More Location
Fudan Universtiy Shanghai Cancer Center
Learn More & Join Trial